- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 324
Precision Ocular adjusts series A to $20.6m
VIB-affiliated V-Bio Ventures has joined a series A round for the retinal treatment developer that already included Imperial Innovations.
Jul 19, 2016Alphabet Energy goes from B to C round
The waste heat-to-energy technology developer has raised $23.5m in a series C round led by Schlumberger and backed by GM Ventures.
Jul 15, 2016Alphabet Energy goes from B to C round
The waste heat-to-energy technology developer has raised $23.5m in a series C round led by Schlumberger and backed by GM Ventures.
Jul 15, 2016Endotronix records $32m series C
OSF Healthcare's investment arm and an unnamed corporate backer both contributed to the heart patient monitor developer's latest round.
Jul 15, 2016Cheetah Mobile proves key as Kika Tech raises $33m
Cheetah Mobile has co-led a series B extension for smartphone keyboard app developer Kika Tech, adding to a $30.6m first tranche closed in February.
Jul 15, 2016Bay Dynamics shores up funding with $23m
The series B round featured corporate venturing unit Comcast Ventures, which led the cybersecurity software provider's $8m in series A funding in 2014.
Jul 14, 2016Intel helps True Fit tailor $25m series B
Intel Capital took part in a funding round for True Fit, 18 months after the retail software developer attracted $15m from investors including Novel Group.
Jul 14, 2016Sapience evolves to series A stage with $22.5m
Celgene has backed a funding round for oncology treatment developer Sapience Therapeutics, a spinout of Columbia University.
Jul 13, 2016Sapience evolves to series A stage with $22.5m
Celgene has backed a funding round for oncology treatment developer Sapience Therapeutics that also included corporate-backed technology advisory firm TaiAn Technologies.
Jul 13, 2016Zymeworks hooks up with Celgene for funding
Celgene has contributed an undisclosed amount to the $24m in funding Zymeworks just raised, as part of a collaboration and licensing partnership.
Jul 12, 2016About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


